Incorporating placental tissue in cord blood banking for stem cell transplantation

References

• Parolini O, De D, Rodrigues MF, et al. Placental stem/progenitor cells: isolation and characterization, in perinatal stem cells. Atala A, Murphy SV, Editors. New York, NY: Springer Science; 2014. p. 373.
   Google Scholar
• Parolini O, Soncini M. Human placenta: a source of progenitor/stem cells? J Reprod Med Endokrinol. 2006;3:117–126.
   Google Scholar
• Parolini O, Soncini M. Placenta as a source of stem cells and as a key organ for fetomaternal tolerance, in regenerative medicine using pregnancy-specific biological substances. Bhattacharya N, Stubblefield P, Editors. London: Springer-Verlag; 2011. p. 460.
   Google Scholar
• Hirschi KK. Hemogenic endothelium during development and beyond. Blood. 2012;119:4823–4827.
   PubMed Web of Science ®Google Scholar
• Gekas C, Dieterlen-Lievre F, Orkin SH, et al. The placenta is a niche for hematopoietic stem cells. Dev Cell. 2005;8:365–375.
   PubMed Web of Science ®Google Scholar
• Dzierzak E, Robin C. Placenta as a source of hematopoietic stem cells. Trends Mol Med. 2010;16:361–367.
   PubMed Web of Science ®Google Scholar
• Robin C, Dzierzak E. Preparation of hematopoietic stem and progenitor cells from the human placenta. Curr Protoc Stem Cell Biol. 2010;2: Chapter Unit 2A 9.
   PubMedGoogle Scholar
• Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172:603–606.
   PubMed Web of Science ®Google Scholar
• Billingham RE, Medawar PB. Desensitization to skin homografts by injections of donor skin extracts. Ann Surg. 1953;137:444–449.
   PubMed Web of Science ®Google Scholar
• von Rango U. Fetal tolerance in human pregnancy – a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett. 2008;115:21–32.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Iwatani Y, Kaneda T, et al. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol. 1997;37:368–377.
   PubMed Web of Science ®Google Scholar
• Croy BA, He H, Esadeg S, et al. Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction. 2003;126:149–160.
   PubMed Web of Science ®Google Scholar
• Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006;6:584–594.
   PubMed Web of Science ®Google Scholar
• Hanna J, Mandelboim O. When killers become helpers. Trends Immunol. 2007;28:201–206.
   PubMed Web of Science ®Google Scholar
• Nagamatsu T, Schust DJ. The contribution of macrophages to normal and pathological pregnancies. Am J Reprod Immunol. 2010;63:460–471.
   PubMed Web of Science ®Google Scholar
• Gustafsson C, Mjosberg J, Matussek A, et al. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One. 2008;3:e2078.
   PubMed Web of Science ®Google Scholar
• Cupurdija K, Azzola D, Hainz U, et al. Macrophages of human first trimester decidua express markers associated to alternative activation. Am J Reprod Immunol. 2004;51:117–122.
   PubMed Web of Science ®Google Scholar
• Lidstrom C, Matthiesen L, Berg G, et al. Cytokine secretion patterns of NK cells and macrophages in early human pregnancy decidua and blood: implications for suppressor macrophages in decidua. Am J Reprod Immunol. 2003;50:444–452.
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Mottonen M, Alanen A, et al. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol. 2004;136:373–378.
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, Shima T, et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63:601–610.
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Darmochwal-Kolarz D, Suzuki D, et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol. 2007;149:139–145.
   PubMed Web of Science ®Google Scholar
• Nakashima A, Ito M, Shima T, et al. Accumulation of IL-17-positive cells in decidua of inevitable abortion cases. Am J Reprod Immunol. 2010;64:4–11.
   PubMed Web of Science ®Google Scholar
• Mjosberg J, Berg G, Jenmalm MC, et al. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod. 2010;82:698–705.
   PubMed Web of Science ®Google Scholar
• Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000;18:217–242.
   PubMed Web of Science ®Google Scholar
• Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol. 2001;2:102–107.
   PubMed Web of Science ®Google Scholar
• PrabhuDas M, Bonney E, Caron K, et al. Immune mechanisms at the maternal–fetal interface: perspectives and challenges. Nat Immunol. 2015;16:328.
   PubMed Web of Science ®Google Scholar
• Faunce DE, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol. 2002;169:31–38.
   PubMed Web of Science ®Google Scholar
• Hornung D, Bentzien F, Wallwiener D, et al. Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod. 2001;7:163–168.
   PubMed Web of Science ®Google Scholar
• Fraccaroli L, Alfieri J, Leiros CP, et al. Immunomodulatory effects of chemokines during the early implantation window. Front Biosci (Elite Ed). 2009;1:288–298.
   PubMedGoogle Scholar
• Magatti M, De Munari S, Vertua E, et al. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells. 2008;26:182–192.
   PubMed Web of Science ®Google Scholar
• Magatti M, De Munari S, Vertua E, et al. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 2009;18:899–914.
   PubMed Web of Science ®Google Scholar
• Magatti M, Caruso M, De Munari S, et al. Human amniotic membrane-derived mesenchymal and epithelial cells exert different effects on monocyte-derived dendritic cell differentiation and function. Cell Transplant. 2015;24:1733–1752.
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Gibelli L, Tosini A, et al. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant. 2009;18:405–422.
   PubMed Web of Science ®Google Scholar
• Sant’Anna LB, Cargnoni A, Ressel L, et al. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model. Cell Transplant. 2011;20:441–453.
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Farigu S, Cotti Piccinelli E, et al. Effect of human amniotic epithelial cells on pro-fibrogenic resident hepatic cells in a rat model of liver fibrosis. J Cell Mol Med. 2018 Feb;22(2):1202–1213.
   Web of Science ®Google Scholar
• SantAnna LB, Hage R, Cardoso MA, et al. Antifibrotic effects of human amniotic membrane transplantation in established biliary fibrosis induced in rats. Cell Transplant. 2016;25:2245–2257.
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Di Marcello M, Campagnol M, et al. Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant. 2009;18:1147–1159.
   PubMed Web of Science ®Google Scholar
• Parolini O, Souza-Moreira L, O’Valle F, et al. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders. Arthritis Rheumatol. 2014;66:327–339.
   PubMed Web of Science ®Google Scholar
• Pischiutta F, Brunelli L, Romele P, et al. Protection of brain injury by amniotic mesenchymal stromal cell-secreted metabolites. Crit Care Med. 2016;44:e1118–e1131.
   PubMed Web of Science ®Google Scholar
• Rossi D, Pianta S, Magatti M, et al. Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS One. 2012;7:e46956.
   PubMed Web of Science ®Google Scholar
• Pianta S, Bonassi Signoroni P, Muradore I, et al. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets. Stem Cell Rev. 2015;11:394–407.
   PubMed Web of Science ®Google Scholar
• Magatti M, Vertua E, De Munari S, et al. Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features. J Tissue Eng Regen Med. 2017 Oct;11(10):2895–2911.
   Web of Science ®Google Scholar
• Cargnoni A, Ressel L, Rossi D, et al. Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis. Cytotherapy. 2012;14:153–161.
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Piccinelli EC, Ressel L, et al. Conditioned medium from amniotic membrane-derived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured mice-specificity of the effects and insights into possible mechanisms. Cytotherapy. 2014;16:17–32.
   PubMed Web of Science ®Google Scholar
• Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the First International Workshop on Placenta Derived Stem Cells. Stem Cells. 2008;26:300–311.
   PubMed Web of Science ®Google Scholar
• Soncini M, Vertua E, Gibelli L, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1:296–305.
   PubMed Web of Science ®Google Scholar
• Bailo M, Soncini M, Vertua E, et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004;78:1439–1448.
   PubMed Web of Science ®Google Scholar
• In ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338–1345.
   PubMed Web of Science ®Google Scholar
• Ilancheran S, Michalska A, Peh G, et al. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. 2007;77:577–588.
   PubMed Web of Science ®Google Scholar
• Portmann-Lanz CB, Schoeberlein A, Huber A, et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol. 2006;194:664–673.
   PubMed Web of Science ®Google Scholar
• Igura K, Zhang X, Takahashi K, et al. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy. 2004;6:543–553.
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Nakajima H, Sugiyama D, et al. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells. 2004;22:649–658.
   PubMed Web of Science ®Google Scholar
• Castrechini NM, Murthi P, Gude NM, et al. Mesenchymal stem cells in human placental chorionic villi reside in a vascular niche. Placenta. 2010;31:203–212.
   PubMed Web of Science ®Google Scholar
• Abumaree MH, Al Jumah MA, Kalionis B, et al. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Rev. 2013;9:16–31.
   PubMed Web of Science ®Google Scholar
• Roselli EA, Lazzati S, Iseppon F, et al. Fetal mesenchymal stromal cells from cryopreserved human chorionic villi: cytogenetic and molecular analysis of genome stability in long-term cultures. Cytotherapy. 2013;15:1340–1351.
   PubMed Web of Science ®Google Scholar
• Abomaray FM, Al Jumah MA, Alsaad KO, et al. Phenotypic and functional characterization of mesenchymal stem/multipotent stromal cells from decidua basalis of human term placenta. Stem Cells Int. 2016;2016:5184601.
   PubMedGoogle Scholar
• Macias MI, Grande J, Moreno A, et al. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol. 2010;203:495 e9– e23.
   Web of Science ®Google Scholar
• Troyer DL, Weiss ML. Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26:591–599.
   PubMed Web of Science ®Google Scholar
• La Rocca G, Anzalone R, Corrao S, et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol. 2009;131:267–282.
   PubMed Web of Science ®Google Scholar
• La Rocca G, Anzalone R, Farina F. The expression of CD68 in human umbilical cord mesenchymal stem cells: new evidences of presence in non-myeloid cell types. Scand J Immunol. 2009;70:161–162.
   PubMed Web of Science ®Google Scholar
• Magatti M, Abumaree MH, Silini AR, et al. The immunomodulatory features of mesenchymal stromal cells derived from wharton’s jelly, amniotic membrane and chorionic villi. Parolini O, Editor. In vitro and in vivo data, in placenta: the Tree of Life. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2016. p. 91–128.
   Google Scholar
• Yamahara K, Harada K, Ohshima M, et al. Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells. PLoS ONE. 2014;9:e88319.
   PubMed Web of Science ®Google Scholar
• Talwadekar MD, Kale VP, Limaye LS. Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts-a paired sample study. Sci Rep. 2015;5:15784.
   PubMed Web of Science ®Google Scholar
• Choi YS, Park Y-B, Ha C-W, et al. Different characteristics of mesenchymal stem cells isolated from different layers of full term placenta. PLoS ONE. 2017;12:e0172642.
   PubMed Web of Science ®Google Scholar
• Wu M, Zhang R, Zou Q, et al. Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord. Sci Rep. 2018;8:5014.
   PubMed Web of Science ®Google Scholar
• Araujo AB, Salton GD, Furlan JM, et al. Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord. Cytotherapy. 2017;19:577–585.
   PubMed Web of Science ®Google Scholar
• Vangsness CT Jr., Sternberg H, Harris L. Umbilical cord tissue offers the greatest number of harvestable mesenchymal stem cells for research and clinical application: a literature review of different harvest sites. Arthroscopy. 2015;31:1836–1843.
   PubMed Web of Science ®Google Scholar
• Davis J. Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J. 1910;15:15.
   Google Scholar
• Stern M. The grafting of preserved amniotic membranes to burned and ulcerated surfaces, substituting skin grafts. JAMA. 1913;60:973.
   Google Scholar
• Sabella N. Use of fetal membranes in skin grafting. Med Rec NY. 1913;83:478–480.
   Google Scholar
• Brindeau A. Creation d’un vagin artificiel A l’aide des membranes ovulaires d’un oeuf A terme. J Gynecol Obstet Biol Reprod (Paris). 1934;13:821–824.
   Google Scholar
• Burger K. Weitere erfahrungen iiber die kunstliche scheidenbildung mit eihauten. Zentralbl Gynäkol. 1947;69:1153–1154.
   Google Scholar
• De Rotth A. Plastic repair of conjunctival defects with fetal membranes. Archives of Ophthalmology. 1940;23:522.
   Google Scholar
• Sorsby A, Haythorne J, Reed H. Further experience with amniotic membrane grafts in caustic burns of the eye. Br J Ophthalmol. 1947;31:409–418.
   PubMed Web of Science ®Google Scholar
• Sorsby A, Symons HM. Amniotic membrane grafts in caustic burns of the eye (burns of the second degree). Br J Ophthalmol. 1946;30:337–345.
   Web of Science ®Google Scholar
• Lee S-H, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303–312.
   PubMed Web of Science ®Google Scholar
• Liu J, Sheha H, Fu Y, et al. Update on amniotic membrane transplantation. Expert Rev Ophthalmol. 2010;5:645–661.
   PubMedGoogle Scholar
• Riau AK, Beuerman RW, Lim LS, et al. Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction. Biomaterials. 2010;31:216–225.
   PubMed Web of Science ®Google Scholar
• Dua HS, Gomes JA, King AJ, et al. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49:51–77.
   PubMed Web of Science ®Google Scholar
• Kesting MR, Wolff KD, Nobis CP, et al. Amniotic membrane in oral and maxillofacial surgery. Oral Maxillofac Surg. 2014;18:153–164.
   PubMedGoogle Scholar
• Lo V, Pope E. Amniotic membrane use in dermatology. Int J Dermatol. 2009;48:935–940.
   PubMed Web of Science ®Google Scholar
• Silini AR, Cargnoni A, Magatti M, et al. The long path of human placenta, and its derivatives, in regenerative medicine. Front Bioeng Biotechnol. 2015;3:162.
   PubMedGoogle Scholar
• Rizk M, Aziz J, Shorr R, et al. Cell-based therapy using umbilical cord blood for novel indications in regenerative therapy and immune modulation: an updated systematic scoping review of the literature. Biol Blood Marrow Transplant. 2017;23:1607–1613.
   PubMed Web of Science ®Google Scholar
• Can A, Celikkan FT, Cinar O. Umbilical cord mesenchymal stromal cell transplantations: a systemic analysis of clinical trials. Cytotherapy. 2017;19:1351–1382.
   PubMed Web of Science ®Google Scholar
• Mayer L, Pandak WM, Melmed GY, et al. Safety and tolerability of human placenta-derived cells (pda001) in treatment-resistant Crohn’s Disease: a Phase I Study. Inflamm Bowel Dis. 2013;19:754–760.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Bowen JD, Huddlestone J, et al. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult Scler Relat Disord. 2014;3:696–704.
   PubMed Web of Science ®Google Scholar
• Jiang R, Han Z, Zhuo G, et al. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med. 2011;5:94–100.
   PubMedGoogle Scholar
• Chambers DC, Enever D, Ilic N, et al. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 2014;19:1013–1018.
   PubMed Web of Science ®Google Scholar
• Kaipe H, Carlson LM, Erkers T, et al. Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients. Stem Cells Dev. 2015;24:1471–1482.
   Web of Science ®Google Scholar
• Platt MJ. Outcomes in preterm infants. Public Health. 2014;128:399–403.
   PubMed Web of Science ®Google Scholar
• Augustine S, Avey MT, Harrison B, et al. Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: systematic review and meta-analysis of preclinical studies. Stem Cells Transl Med. 2017;6:2079–2093.
   PubMed Web of Science ®Google Scholar
• Pierro M, Thebaud B, Soll R. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017;11:Cd011932.
   PubMed Web of Science ®Google Scholar
• Anzalone R, Lo Iacono M, Corrao S, et al. New emerging potentials for human Wharton’s jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev. 2010;19:423–438.
   PubMed Web of Science ®Google Scholar
• Manuelpillai U, Tchongue J, Lourensz D, et al. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl(4)-treated mice. Cell Transplant. 2010;19:1157–1168.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Jung J, Na KH, et al. Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases. J Cell Biochem. 2010;111:1453–1463.
   PubMed Web of Science ®Google Scholar
• Jung J, Choi JH, Lee Y, et al. Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism. Stem Cells. 2013;31:1584–1596.
   PubMed Web of Science ®Google Scholar
• Ricci E, Vanosi G, Lindenmair A, et al. Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model. Cell Tissue Bank. 2013;14:475–488.
   PubMed Web of Science ®Google Scholar
• Manuelpillai U, Lourensz D, Vaghjiani V, et al. Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis. PLoS One. 2012;7:e38631.
   PubMed Web of Science ®Google Scholar
• Moodley Y, Vaghjiani V, Chan J, et al. Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS One. 2013;8:e69299.
   PubMed Web of Science ®Google Scholar
• Moodley Y, Ilancheran S, Samuel C, et al. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am J Respir Crit Care Med. 2010;182:643–651.
   PubMed Web of Science ®Google Scholar
• Murphy S, Lim R, Dickinson H, et al. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplant. 2011;20:909–923.
   PubMed Web of Science ®Google Scholar
• Vosdoganes P, Wallace EM, Chan ST, et al. Human amnion epithelial cells repair established lung injury. Cell Transplant. 2013;22:1337–1349.
   PubMed Web of Science ®Google Scholar
• Vosdoganes P, Hodges RJ, Lim R, et al. Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. Am J Obstet Gynecol. 2011;205(p. 156):e26–33.
   Google Scholar
• Westover A, Melville JM, McDonald C, et al. Effect of human amnion epithelial cells on the acute inflammatory response in fetal sheep. Front Physiol. 2017;8:871.
   PubMed Web of Science ®Google Scholar
• Roy R, Kukucka M, Messroghli D, et al. Epithelial-to-mesenchymal transition enhances the cardioprotective capacity of human amniotic epithelial cells. Cell Transplant. 2015;24:985–1002.
   PubMed Web of Science ®Google Scholar
• Santos Nascimento D, Mosqueira D, Sousa LM, et al. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Stem Cell Res Ther. 2014;5:5.
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu X, Zhang Y, et al. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction. Exp Cell Res. 2016;344:30–39.
   PubMed Web of Science ®Google Scholar
• Passipieri JA, Kasai-Brunswick TH, Suhett G, et al. Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway. Stem Cell Res Ther. 2014;5:102.
   PubMed Web of Science ®Google Scholar
• Liu YH, Peng KY, Chiu YW, et al. Human placenta-derived multipotent cells (hpdmcs) modulate cardiac injury: from bench to small and large animal myocardial ischemia studies. Cell Transplant. 2015;24:2463–2478.
   PubMed Web of Science ®Google Scholar
• Chen HJ, Chen CH, Chang MY, et al. Human placenta-derived adherent cells improve cardiac performance in mice with chronic heart failure. Stem Cells Transl Med. 2015;4:269–275.
   PubMed Web of Science ®Google Scholar
• Roy R, Brodarac A, Kukucka M, et al. Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model. J Surg Res. 2013;185:70–83.
   PubMed Web of Science ®Google Scholar
• Bollini S, Silini AR, Banerjee A, et al. Cardiac restoration stemming from the placenta tree: insights from fetal and perinatal cell biology. Front Physiol. 2018;9:385.
   PubMed Web of Science ®Google Scholar
• Li Y, Li H, Cao Y, et al. Placentaderived mesenchymal stem cells improve airway hyperresponsiveness and inflammation in asthmatic rats by modulating the Th17/Treg balance. Mol Med Rep. 2017;16:8137–8145.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Chung K, Pivetti C, et al. Fetal surgical repair with placenta-derived mesenchymal stromal cell engineered patch in a rodent model of myelomeningocele. J Pediatr Surg. 2017 Oct 12. pii: S0022-3468(17)30662-0.
   Web of Science ®Google Scholar
• Wang A, Brown EG, Lankford L, et al. Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele. Stem Cells Transl Med. 2015;4:659–669.
   PubMed Web of Science ®Google Scholar
• Kabagambe S, Keller B, Becker J, et al. Placental mesenchymal stromal cells seeded on clinical grade extracellular matrix improve ambulation in ovine myelomeningocele. J Pediatr Surg. 2017 Oct 12. pii: S0022-3468(17)30654-1.
   Web of Science ®Google Scholar
• Tian T, Yu Z, Zhang N, et al. Modified acellular nerve-delivering PMSCs improve functional recovery in rats after complete spinal cord transection. Biomater Sci. 2017;5:2480–2492.
   PubMed Web of Science ®Google Scholar
• Hirko AC, Dallasen R, Jomura S, et al. Modulation of inflammatory responses after global ischemia by transplanted umbilical cord matrix stem cells. Stem Cells. 2008;26:2893–2901.
   PubMed Web of Science ®Google Scholar
• Jomura S, Uy M, Mitchell K, et al. Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells. Stem Cells. 2007;25:98–106.
   PubMed Web of Science ®Google Scholar
• Lin YC, Ko TL, Shih YH, et al. Human umbilical mesenchymal stem cells promote recovery after ischemic stroke. Stroke. 2011;42:2045–2053.
   PubMed Web of Science ®Google Scholar
• Liu YH, Vaghjiani V, Tee JY, et al. Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis. PLoS One. 2012;7:e35758.
   PubMed Web of Science ®Google Scholar
• McDonald CA, Payne NL, Sun G, et al. Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis. J Neuroinflammation. 2015;12:112.
   PubMed Web of Science ®Google Scholar
• Donders R, Vanheusden M, Bogie JF, et al. Human Wharton’s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis. Cell Transplant. 2015;24(10):2077–2098.
   Web of Science ®Google Scholar
• McCulloh CJ, Olson JK, Zhou Y, et al. Stem cells and necrotizing enterocolitis: a direct comparison of the efficacy of multiple types of stem cells. J Pediatr Surg. 2017;52:999–1005.
   PubMed Web of Science ®Google Scholar
• Rager TM, Olson JK, Zhou Y, et al. Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis. J Pediatr Surg. 2016;51:942–947.
   PubMed Web of Science ®Google Scholar
• Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013; 122:491–498.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–1178.
   PubMed Web of Science ®Google Scholar
• Barker JN, Byam CE, Kernan NA, et al. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biol Blood Marrow Transplant. 2010;16:1541–1548.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989;86:3828–3832.
   PubMed Web of Science ®Google Scholar
• Lu L, Xiao M, Shen RN, et al. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood. 1993;81:41–48.
   PubMed Web of Science ®Google Scholar
• Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant. 2008;41:207–214.
   PubMed Web of Science ®Google Scholar
• Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–2275.
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343–1347.
   PubMed Web of Science ®Google Scholar
• Ramirez P, Wagner JE, DeFor TE, et al. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant. 2012;47:799–803.
   PubMed Web of Science ®Google Scholar
• Baron F, Nagler A. Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy. Expert Opin Biol Ther. 2017;17:163–174.
   PubMed Web of Science ®Google Scholar
• Milano F, Appelbaum FR, Cord-Blood DC. Transplantation in patients with minimal residual disease. N Engl J Med. 2016;375:2204–2205.
   PubMedGoogle Scholar
• Gluckman E, Ruggeri A, Rocha V, et al. Family-directed umbilical cord blood banking. Haematologica. 2011;96:1700–1707.
   PubMed Web of Science ®Google Scholar
• Sun JM, Song AW, Case LE, et al. Effect of autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy: a randomized, placebo-controlled trial. Stem Cells Transl Med. 2017;6:2071–2078.
   PubMed Web of Science ®Google Scholar
• Dawson G, Sun JM, Davlantis KS, et al. Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder: results of a single‐center phase i open‐label trial. Stem Cells Transl Med. 2017;6:1332–1339.
   PubMed Web of Science ®Google Scholar
• Kiernan J, Damien P, Monaghan M, et al. Clinical studies of ex vivo expansion to accelerate engraftment after umbilical cord blood transplantation: a systematic review. Transfus Med Rev. 2017;31:173–182.
   PubMed Web of Science ®Google Scholar
• Mehta RS, Saliba RM, Cao K, et al. Ex vivo mesenchymal precursor cell-expanded cord blood transplantation after reduced-intensity conditioning regimens improves time to neutrophil recovery. Biol Blood Marrow Transplant. 2017;23:1359–1366.
   PubMed Web of Science ®Google Scholar
• De Lima M, McNiece I, Robinson SN, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med. 2012;367:2305–2315.
   PubMed Web of Science ®Google Scholar
• Munneke JM, Spruit MJ, Cornelissen AS, et al. The potential of mesenchymal stromal cells as treatment for severe steroid-refractory acute graft-versus-host disease: a critical review of the literature. Transplantation. 2016;100:2309–2314.
   PubMed Web of Science ®Google Scholar
• Ball LM, Bernardo ME, Roelofs H, et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007;110:2764–2767.
   PubMed Web of Science ®Google Scholar
• Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104:2752–2760.
   PubMed Web of Science ®Google Scholar
• Schwarz TM, Leicht SF, Radic T, et al. Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy. Arterioscler Thromb Vasc Biol. 2012;32:e13–e21.
   PubMed Web of Science ®Google Scholar
• Flex A, Biscetti F, Iachininoto MG, et al. Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model. Thromb Res. 2016;141:106–111.
   PubMed Web of Science ®Google Scholar
• Lin RZ, Moreno-Luna R, Li D, et al. Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling. Proc Natl Acad Sci U S A. 2014;111:10137–10142.
   PubMed Web of Science ®Google Scholar
• Shafiee A, Patel J, Wong HY, et al. Priming of endothelial colony-forming cells in a mesenchymal niche improves engraftment and vasculogenic potential by initiating mesenchymal transition orchestrated by NOTCH signaling. Faseb J. 2017;31:610–624.
   PubMed Web of Science ®Google Scholar
• Burkhart HM, Qureshi MY, Peral SC, et al. Regenerative therapy for hypoplastic left heart syndrome: first report of intraoperative intramyocardial injection of autologous umbilical-cord blood-derived cells. J Thorac Cardiovasc Surg. 2015;149:e35–e7.
   PubMed Web of Science ®Google Scholar
• Kucia M, Zuba-Surma EK, Wysoczynski M, et al. Adult marrow-derived very small embryonic-like stem cells and tissue engineering. Expert Opin Biol Ther. 2007;7:1499–1514.
   PubMed Web of Science ®Google Scholar
• Wojakowski W, Kucia M, Zuba-Surma E, et al. Very small embryonic-like stem cells in cardiovascular repair. Pharmacol Ther. 2011;129:21–28.
   PubMed Web of Science ®Google Scholar
• Iachininoto MG, Capodimonti S, Podda MV, et al. In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells. Cytotherapy. 2015;17:1627–1637.
   PubMed Web of Science ®Google Scholar